Late opening today 12/22/22
SOMA is closed for the rest of today! Please stay tuned for updates on our Thursday hours
¡SOMA está cerrado por el resto del día! Estén atentos a las para ver nuestro horario de jueves.
Late opening today 12/22/22
It is cold today! We are working reduced hours todays and will be opening at 12 pm (noon)!
Please avoid any unnecessary travel today and stay safe! In this weather it is possible to get frost bite in under ten minutes!
¡Esta haciendo frio! ¡Vamos a trabajar un horario reducido hoy y abriremos a las 12 p.m. (mediodía)!
¡Evite cualquier viaje innecesario hoy y manténgase seguro! ¡Con este clima es posible congelarse en menos de diez minutos!
Emerging studies on ketamine use in medicine
Staying up to date.
Part of our success has been to have a continuing improving model when it comes to our patient care. We carefully monitor medical journals as well as research studies to stay up to date on what we offer our patients. Our group of medical directors uses the latest information to make sure our patient protocols are as up to date as possible. Below are some of there recent studies we have been keeping an eye one;
Parte de nuestro éxito ha sido tener un modelo de mejoramiento contino en lo que respecta a la atención de nuestros pacientes. Supervisamos cuidadosamente las revistas médicas y los estudios de investigación para estar al día sobre lo que ofrecemos a nuestros pacientes. Nuestro grupo de directores médicos utiliza la información más reciente para asegurarse de que los protocolos de nuestros pacientes estén lo más actualizados posible. A continuación se presentan algunos de los estudios recientes que hemos estado vigilando;
Ketamine and Therapy could help treat alcoholism
A new study on treating alcoholism with ketamine. This particular study is looking at treating severe alcohol use disorder. Very low dose infusions are given over a period of 1 to 2 months. Paired with therapy and educational sessions they are hoping to reduce the dependency on alcohol. Find out more by reading the article
We will be following closely as we seek new methods to treat our patients
Hay un nuevo estudio sobre el tratamiento del alcoholismo con ketamina. Este estudio en particular busca tratar el trastorno grave por consumo del alcohol. Las infusiones de dosis muy bajas se administran durante un período de 1 a 2 meses. Junto con la terapia y las sesiones educativas, esperan reducir la dependencia del alcohol. Obtenga más información leyendo el artículo
Estaremos siguiendo el estudio para ver si hay nuevos métodos para tratar a nuestros pacientes.
Esketamine Nasal Spray Bests Quetiapine XR in Difficult-to-Treat Depression
According to this article on MPR, results have been announced from a trial phase that compared
“the short- and long-term efficacy, safety, and tolerability of esketamine nasal spray to quetiapine extended-release (XR) in adults with treatment-resistant major depressive disorder.”
In other words, patients who were given Spravato® were shown to have achieved remission at week 8 and remain relapse free in the longer term up to week 32 compared to patients on Seroquel XR.
Según este artículo sobre MPR, se han anunciado los resultados de una fase de ensayo que comparó
“la eficacia, la seguridad y la tolerabilidad a corto y largo plazo del aerosol nasal de esketamina con la liberación prolongada (XR) de quetiapina en adultos con enfermedades graves resistentes al tratamiento para desordenes depresivos.”
(traducido internamente por SOMA)
En otras palabras, se demostró que los pacientes que recibieron Spravato® lograron la remisión en la semana 8 y permanecieron libres de recaídas a largo plazo hasta la semana 32 en comparación con los pacientes que recibieron Seroquel XR.
We are a Spravato REMS certified clinic and would be happy to help you seek treatment today.
SPRAVATO® is the first prescription nasal spray, taken with an oral antidepressant, for:
- Adults with treatment-resistant depression (TRD). In the SPRAVATO® clinical trials, TRD was diagnosed in adults who were struggling with major depressive disorder and had not responded adequately to at least two different antidepressants of adequate dose and duration in the current episode.
- Depressive symptoms in adults with major depressive disorder with suicidal thoughts or actions
Somos una clínica certificada por Spravato® REMS y nos complacería ayudarlo a buscar tratamiento hoy.
SPRAVATO® (eskatamine) es un medicamento recetado que se utiliza en conjunto con un antidepresivo oral para el tratamiento de:
- Adultos con depresión resistente al tratamiento (DRT)
- Síntomas depresivos en adultos con trastorno depresivo mayor (TDM) con pensamientos o acciones suicidas.
Please contact us if you have any questions or check out our Spravato® information page.
- 531-267-0711
- info@southomahamedical.com
SOMA is a Spravato certified REMS center!
What is Spravato® Therapy?
SPRAVATO® (esketamine) is an effective method in treating adults with Major Depressive Disorder (MDD). It is an intranasal prescription medicine, used along with an antidepressant taken by mouth, for Treatment Resistant Depression (TRD) in adults. TRD is defined as the failure of two or more oral antidepressants of adequate dose and duration.
If you are struggling with depression and have tried two or more antidepressants without relief, it’s time to talk to your doctor or schedule an evaluation to see if Spravato® is the answer.
Each treatment lasts about two hours where patients are monitored in a comfortable setting in our clinics. (Due to the side effects of the Spravato® treatment, you are not allowed to drive afterward – you must have a friend, family member, or a ride share service pick you up.) We have a number of available room choices depending on what you like to do during your treatments.
Any specific questions please call us at: 531-267-0711
SPRAVATO® is the first prescription nasal spray, taken with an oral antidepressant, for:
- Adults with treatment-resistant depression (TRD). In the SPRAVATO® clinical trials, TRD was diagnosed in adults who were struggling with major depressive disorder and had not responded adequately to at least two different antidepressants of adequate dose and duration in the current episode.
- Depressive symptoms in adults with major depressive disorder with suicidal thoughts or actions
Helpful Links: each of the articles below highlight the benefits of Spravato® treatments. All of the information used in this post is from Spravato® (esketamine) and can be found below;
- Spravato main page
- Spravato for treatment resistant depression
- Spravato for Major Depressive Disorder with suicidal thoughts or actions
Please contact us if you have any questions or check out our Spravato® information page.
- 531-267-0711
- info@southomahamedical.com
Ashley Wallen PA-C !!New Provider Welcome!!
We are excited to welcome Ashley Wallen PA-C to our staff at South Omaha Medical Associates!
Ashley grew up in a small Nebraska town. She graduated from the University of Nebraska Lincoln with a Bachelor’s of Science. She then went on to earn her Masters of Physician Assistant Studies at University of Nebraska Medical Center. She has been practicing family medicine since.
Ashley is passionate about wellness and preventative medicine and is excited to bring her experience to SOMA! She has experience in treating both acute and chronic conditions in patients of all ages. In addition, she believes strongly in providing patients with comprehensive healthcare, including mental health.
We are available for walk in availability and same day appointments!
Ashley Wallen is available M-F 9-4pm. Please reach out of you have any questions. She is available for a number of services including telehealth availability! We are currently accepting patients and are happy to schedule as soon as possible.
If you are an existing patient of our clinic and connected to our Patient Fusion profile you are now able to schedule online! Login into your Patient profile and follow the times below to schedule with Ashley!
Call us today to learn more: 402-731-9100
August Ketamine promotion for Omaha and surrounding areas
For the month of August we would like to offer the following promotions on our mental health services (please call to receive promo pricing!):
- Current Ketamine IV patients: book your next booster appointment and receive $50 off (must be paid at time of booking)
- New IV patients requiring physicals: book your consult & ketamine infusions and receive $100 off your last infusion (must be paid at time of booking)
- All Referrals: All patients that send referrals to our practice who book an appointment or consult will get $50 off of their next ketamine infusion (valid 1 per person & can be combined). For both you and your referral!
Our bilingual Family Practice medical clinic is ready to help you with an August ketamine promotion on our IV infusions. We have been constantly improving on our methods and work flows to optimize the patient experience. For being patient during our growth we would like to extend a promotion for all current and new patients.
Different Care Options
Although a big focus at our clinic is Ketamine IV therapy. We also encourage patients to look into Esketamine, an oral inhalant alternative. We have partnered with Spravato to become an available treatment center here in Omaha! Please reach out to us to schedule and see about starting the process. Those patients who are already eligible or in the program can now choose us as a supported center. Additionally, many insurance carriers reimburse the treatment and we have become experts at navigating the insurance process.
What is SPRAVATO® (esketamine) CIII nasal spray? SPRAVATO® is a prescription medicine, used along with an antidepressant taken by mouth to treat: Adults with treatment-resistant depression (TRD)Depressive symptoms in adults with major depressive disorder (MDD) with suicidal thoughts or actions. This is a federally backed program that is covered by most insurance options. Please contact us for specific information regarding reimbursement and becoming eligible.
Helpful Links: each of the articles below highlight the benefits of Spravato Treatments.
- Spravato main page
- Spravato for treatment resistant depression
- Spravato for Major Depressive Disorder with suicidal thoughts or actions
If you know someone who is having suicidal thoughts or ideations please reach out to the national support center by dialing (or texting) #988
GET IN TOUCH
Schedule a Visit
Please contact us if you have any questions or check out our FAQ:
- 531-267-0711
- info@southomahamedical.com
SOMA is proud to announce Spravato!
Ketamine has been studied for treatment of a variety of mental health conditions. It is thought to reset and re-establish connections within the brain to treat resistant depression and rapidly relieve suicidal thoughts.
We have partnered with Spravato to become an available treatment center here in Omaha! Please reach out to us to schedule and see about starting the process. Those patients who are already eligible or in the program can now choose us as a supported center.
Any specific questions please call us at: 531-267-0711
What is SPRAVATO® (esketamine) CIII nasal spray? SPRAVATO® is a prescription medicine, used along with an antidepressant taken by mouth to treat: Adults with treatment-resistant depression (TRD)Depressive symptoms in adults with major depressive disorder (MDD) with suicidal thoughts or actions. This is a federally backed program that is covered by most insurance options. Please contact us for specific information regarding reimbursement and becoming eligible.
SPRAVATO® is the first prescription nasal spray, taken with an oral antidepressant, for:
- Adults with treatment-resistant depressionXIn the SPRAVATO® clinical trials, treatment-resistant depression was diagnosed in adults who were struggling with major depressive disorder and had not responded adequately to at least two different antidepressants of adequate dose and duration in the current episode.
- Depressive symptoms in adults with major depressive disorder with suicidal thoughts or actions
Helpful Links: each of the articles below highlight the benefits of Spravato Treatments
- Spravato main page
- Spravato for treatment resistant depression
- Spravato for Major Depressive Disorder with suicidal thoughts or actions
Please contact us if you have any questions or check out our FAQ:
- 531-267-0711
- info@southomahamedical.com
What is Ketamine-IV Therapy?
Ketamine has been studied for treatment of a variety of mental health conditions. It is thought to reset and re-establish connections within the brain to treat resistant depression and rapidly relieve suicidal thoughts.
We at SOMA see ketamine IV therapy as an adjunct to other therapies and will work closely with your PCP, psychiatrist, and/or therapist to optimize your mental well-being. Our approach uses a low dose of ketamine through a series of infusions that is based on research-backed, consensus guidelines.
What to expect
An initial consultation is done to determine the appropriateness of ketamine therapy and address questions. For best results, our study-supported regimen includes 6 treatment sessions over 2-3 weeks with booster infusions periodically as needed. While some patients may feel improvement in symptoms after only 1 or 2 infusions, we focus on the longer term improvement.
Helpful Links: each of the articles below highlight the benefits of Ketamine IV Therapy for each of the conditions.
Please contact us if you have any questions or check out our FAQ:
- 531-267-0711
- info@southomahamedical.com